BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1974382)

  • 1. Pulmonary effects of long-term beta 2-blockade in healthy subjects: comparative study of metoprolol OROS.
    Bauer K; Rakusan S; Kaik G
    Am Heart J; 1990 Aug; 120(2):473-7. PubMed ID: 1974382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course of the bronchial response to salbutamol after placebo, betaxolol and propranolol.
    Palminteri R; Kaik G
    Eur J Clin Pharmacol; 1983; 24(6):741-5. PubMed ID: 6136412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osmotic release oral drug delivery system of metoprolol in hypertensive asthmatic patients. Pharmacodynamic effects on beta 2-adrenergic receptors.
    Bauer K; Kaik G; Kaik B
    Hypertension; 1994 Sep; 24(3):339-46. PubMed ID: 7916004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CNS-related performance and haemodynamics of metoprolol-Oros and propranolol after single and 3 days dosing in healthy volunteers.
    van Steveninck AL; Pieters MS; Schoemaker HC; Breimer DD; Cohen AF
    Br J Clin Pharmacol; 1993 Feb; 35(2):114-20. PubMed ID: 8443028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.
    Plosker GL; Clissold SP
    Drugs; 1992 Mar; 43(3):382-414. PubMed ID: 1374320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of cardioselectivity of metoprolol OROS and atenolol: a double-blind, placebo-controlled crossover study.
    Tantucci C; Bruni B; Dottorini ML; Peccini F; Motolese M; Lecaillon JB; Sorbini CA; Grassi V
    Am Heart J; 1990 Aug; 120(2):467-72. PubMed ID: 2200257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenoceptor blockade and CNS-related subjective symptoms: a randomized, double-blind, placebo-controlled comparison of metoprolol CR/ZOK, atenolol and propranolol LA in healthy subjects.
    Dimenäs E; Kerr D; Macdonald I
    J Clin Pharmacol; 1990 Feb; 30(S2):S103-7. PubMed ID: 1968912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of airways, tremor and chronotropic responses to inhaled salbutamol in the quantification of beta 2-adrenoceptor blockade.
    Lipworth BJ; Brown RA; McDevitt DG
    Br J Clin Pharmacol; 1989 Jul; 28(1):95-102. PubMed ID: 2570601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of beta-adrenoceptor selectivity of acebutolol and its metabolite diacetolol with metoprolol and propranolol in normal man.
    Thomas MS; Tattersfield AE
    Eur J Clin Pharmacol; 1986; 29(6):679-83. PubMed ID: 2872056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects.
    Kerr D; MacDonald IA; Heller SR; Tattersall RB
    Br J Clin Pharmacol; 1990 Jun; 29(6):685-93. PubMed ID: 1974143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic comparison of an osmotic release oral metoprolol tablet and the metoprolol conventional tablet.
    Feliciano NR; Bouvet AA; Redalieu E; Castellana J; Luders RC; Schwartz DJ; Shum L; Zak S; Arnold JD; Leese PT
    Am Heart J; 1990 Aug; 120(2):483-9. PubMed ID: 2382633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative assessment of bronchial beta-adrenoceptor blockade in man.
    Gribbin HR; Baldwin CJ; Tattersfield AE
    Br J Clin Pharmacol; 1979 Jun; 7(6):551-6. PubMed ID: 37867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man.
    Tattersfield AE; Cragg DJ; Bacon RJ
    Br J Clin Pharmacol; 1984 Sep; 18(3):343-7. PubMed ID: 6148959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of metoprolol OROS with antenolol in the treatment of effort angina pectoris: a randomized double-blind study.
    Floris B; Paoletti G; Pelizza L; Bertulla A; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1991 Apr; 29(4):139-43. PubMed ID: 1906434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind comparison of once-daily metoprolol controlled-release and atenolol in the treatment of Chinese patients with mild to moderate hypertension.
    Chen MF; Yang CY; Chen WJ; Lee CM; Wu CC; Liau CS; Lee YT
    Cardiovasc Drugs Ther; 1995 Jun; 9(3):401-6. PubMed ID: 8527349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multiple dose pharmacokinetic and pharmacodynamic evaluation of conventional and 19/285 Oros formulations of metoprolol in healthy volunteers.
    Grainger SL; John VA; Shotton PA; Smith SE
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):239S-244S. PubMed ID: 4005129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of penbutolol and propranolol on normal airway response to salbutamol.
    Warren JB; Monaghan AT; Clark TJ
    Clin Pharmacol Ther; 1984 Jul; 36(1):47-50. PubMed ID: 6734048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of beta-adrenergic receptor blockade after isamoltane, a 5-HT1-receptor active compound, in healthy volunteers.
    Bauer K; Dietersdorfer F; Kaik G
    Clin Pharmacol Ther; 1993 Jun; 53(6):675-83. PubMed ID: 8099863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-adrenergic function in airways of healthy and asthmatic subjects.
    Gayrard P; Orehek J; Grimaud C; Charpin J
    Thorax; 1975 Dec; 30(6):657-62. PubMed ID: 769241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral platelet count in response to salbutamol before and after adrenergic beta-receptor blockade.
    Fredén K; Olsson LB; Vilén L; Kutti J
    Acta Haematol; 1978; 60(5):310-5. PubMed ID: 30249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.